• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西仑吉肽可抑制骨髓瘤浆细胞的破骨细胞样骨吸收活性。

Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells.

作者信息

Tucci Marco, Stucci Stefania, Felici Claudia, Cafforio Paola, Resta Leonardo, Rossi Roberta, Silvestris Franco

机构信息

Department of Biomedical Sciences and Human Oncology, University of Bari 'Aldo Moro', Bari, Italy.

Department of Emergency and Organ Transplantation, University of Bari 'Aldo Moro', Bari, Italy.

出版信息

Br J Haematol. 2016 Apr;173(1):59-69. doi: 10.1111/bjh.13922. Epub 2016 Jan 5.

DOI:10.1111/bjh.13922
PMID:26728969
Abstract

Cilengitide (CLG) is an inhibitor of both αv β3 and αv β5 integrins, with a defined anti-tumour effect in glioblastoma. Pre-clinical studies demonstrate its ability to restrain the bone resorbing property of metastatic osteotropic tumours and we have previously shown that the disablement of αv β3 in multiple myeloma (MM) plasma cells results in exhaustion of their in vitro osteoclast (OC)-like activity on bone substrate. Here, we investigated the effect of CLG on this functional property of MM cells. Both αv β3 and αv β5 were measured on primary marrow MM cells from 19 patients, and the effect of CLG on proliferation, apoptosis and adhesion was investigated in parallel with MM cell lines and OCs from healthy donors. In addition, the effect of CLG on the capability of malignant plasma cells to produce erosive lacunae on calcium phosphate was explored in relation to the activation of intracellular kinases of molecular pathways of both integrins. Ultrastructural microscopy was used to evaluate the morphological changes in MM cells due to the effect of CLG on cell adhesion. The data from our study demonstrate that CLG restrains the bone resorbing function of MM cells by disabling their adhesion properties. Further investigations in pre-clinical studies of osteotropic tumours are warranted.

摘要

西仑吉肽(CLG)是αvβ3和αvβ5整合素的抑制剂,对胶质母细胞瘤具有明确的抗肿瘤作用。临床前研究表明其具有抑制转移性亲骨性肿瘤骨吸收特性的能力,并且我们之前已经表明,多发性骨髓瘤(MM)浆细胞中αvβ3的失活会导致其在骨基质上的体外破骨细胞(OC)样活性耗竭。在此,我们研究了CLG对MM细胞这一功能特性的影响。检测了19例患者原代骨髓MM细胞上的αvβ3和αvβ5,并与MM细胞系及健康供体的OCs平行研究了CLG对增殖、凋亡和黏附的影响。此外,针对整合素分子途径的细胞内激酶激活情况,探讨了CLG对恶性浆细胞在磷酸钙上产生侵蚀性腔隙能力的影响。利用超微结构显微镜评估了CLG对细胞黏附作用影响下MM细胞的形态变化。我们的研究数据表明,CLG通过破坏MM细胞的黏附特性来抑制其骨吸收功能。亲骨性肿瘤临床前研究有必要进行进一步调查。

相似文献

1
Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells.西仑吉肽可抑制骨髓瘤浆细胞的破骨细胞样骨吸收活性。
Br J Haematol. 2016 Apr;173(1):59-69. doi: 10.1111/bjh.13922. Epub 2016 Jan 5.
2
Bone-resorbing cells in multiple myeloma: osteoclasts, myeloma cell polykaryons, or both?多发性骨髓瘤中的骨吸收细胞:破骨细胞、骨髓瘤细胞多核体,还是两者皆有?
Oncologist. 2009 Mar;14(3):264-75. doi: 10.1634/theoncologist.2008-0087. Epub 2009 Mar 13.
3
Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin.人破骨细胞样细胞上的αvβ3整合素激活后,会响应骨桥蛋白刺激黏附和迁移。
Biochem Biophys Res Commun. 1998 Aug 19;249(2):522-5. doi: 10.1006/bbrc.1998.9180.
4
Cilengitide inhibits metastatic bone colonization in a nude rat model.西仑吉肽抑制裸鼠模型中的转移性骨定植。
Oncol Rep. 2011 Oct;26(4):843-51. doi: 10.3892/or.2011.1373. Epub 2011 Jul 1.
5
Radiation sensitization of glioblastoma by cilengitide has unanticipated schedule-dependency.西仑吉肽对胶质母细胞瘤的放射增敏作用具有意外的时间依赖性。
Int J Cancer. 2009 Jun 1;124(11):2719-27. doi: 10.1002/ijc.24240.
6
Biological aspects of altered bone remodeling in multiple myeloma and possibilities of pharmacological intervention.多发性骨髓瘤中骨重塑改变的生物学特性及药物干预的可能性
Dan Med Bull. 2011 May;58(5):B4277.
7
Effects of cilengitide in osteoclast maturation and behavior.西仑吉肽对破骨细胞成熟及行为的影响。
Exp Cell Res. 2015 Sep 10;337(1):68-75. doi: 10.1016/j.yexcr.2015.07.018. Epub 2015 Jul 21.
8
beta(3) Integrin subunit mediates the bone-resorbing function exerted by cultured myeloma plasma cells.β(3)整合素亚基介导培养的骨髓瘤浆细胞发挥的骨吸收功能。
Cancer Res. 2009 Aug 15;69(16):6738-46. doi: 10.1158/0008-5472.CAN-09-0949. Epub 2009 Aug 4.
9
Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.西仑吉肽通过细胞分离和凋亡诱导靶向小儿神经胶质瘤和神经母细胞瘤细胞。
Anticancer Drugs. 2013 Sep;24(8):818-25. doi: 10.1097/CAD.0b013e328362edc5.
10
Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.扭盘蛇毒素是一种同源二聚体蛇毒解整合素,是破骨细胞附着的有效抑制剂。
J Bone Miner Res. 1998 Mar;13(3):409-14. doi: 10.1359/jbmr.1998.13.3.409.

引用本文的文献

1
Downregulation of ITGβ3 in colon adenocarcinoma reveals poor prognosis by affecting genome stability, cell cycle, and the tumor immune microenvironment.整合素β3(ITGβ3)在结肠腺癌中的表达下调通过影响基因组稳定性、细胞周期和肿瘤免疫微环境揭示了不良预后。
Front Oncol. 2023 Jan 20;12:1047648. doi: 10.3389/fonc.2022.1047648. eCollection 2022.
2
The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.在临床前模型中,表皮生长因子样结构域蛋白7-整合素β3- Kruppel样因子2轴可提高多发性骨髓瘤的存活率。
Blood Adv. 2020 Mar 24;4(6):1021-1037. doi: 10.1182/bloodadvances.2019001002.
3
ITGB3/CD61: a hub modulator and target in the tumor microenvironment.
整合素β3/CD61:肿瘤微环境中的关键调节因子和靶点
Am J Transl Res. 2019 Dec 15;11(12):7195-7208. eCollection 2019.
4
A First Report on [F]FPRGD PET/CT Imaging in Multiple Myeloma.多发性骨髓瘤中 [F]FPRGD PET/CT 成像的首次报告。
Contrast Media Mol Imaging. 2017 Jul 27;2017:6162845. doi: 10.1155/2017/6162845. eCollection 2017.
5
A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins.RGD 结合整合素配体的活性和选择性特征的综合评价。
Sci Rep. 2017 Jan 11;7:39805. doi: 10.1038/srep39805.
6
Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model.靶向αvβ3和αvβ5整合素可抑制胫骨内异种移植骨肉瘤小鼠模型中的肺转移。
Oncotarget. 2016 Aug 23;7(34):55141-55154. doi: 10.18632/oncotarget.10461.